The Hong Kong Exchanges and Clearing Limited and the stock exchange of Hong Kong Limited shall not be responsible for the contents of this announcement, nor make any statement on its accuracy or completeness, and expressly state that they will not be liable for any loss arising from the whole or any part of the contents of this announcement or reliance on such contents.
Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd
(a company limited by shares incorporated in the people’s Republic of China)
(Stock Code: 3759)
Notice of board meeting
The board of directors of the company hereby proposes to pay dividends to the company and its subsidiaries for the year ended (December 31, 2023) (including the final meeting of the board of directors) on December 31, 2023).
Accept the order of the board of directors
Chairman of Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd
Dr. Lou Bailiang
Beijing, people’s Republic of China, March 11, 2022. On the date of this announcement, the board of directors includes executive directors Dr. Lou Bailiang, Mr. Lou Xiaoqiang and Ms. Zheng Bei; Non executive directors: Mr. Chen Pingjin, Mr. Hu Baifeng, Mr. Li Jiaqing and Mr. Zhou Hongbin; Independent non-executive directors: Mr. Dai Lixin, Ms. Chen Guoqin, Mr. Zeng kunhong and Mr. Yu Jian Identification only
